Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Lyne Lavoie
Observed name:
L. Lavoie
Institution:
Québec-Océan
Observed institutions:
Eastern Virginia Medical School,
Q & T Research,
Québec-Océan
OpenAlex ID:
A5089622993
Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause
2016
·
Fernand Labrie
, David F. Archer
, et al.
·
Menopause The Journal of The North American Menopause Society
·
251
Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women
2009
·
Fernand Labrie
, David Archer
, et al.
·
Menopause The Journal of The North American Menopause Society
·
191
Intravaginal dehydroepiandrosterone (Prasterone), a physiological and highly efficient treatment of vaginal atrophy
2009
·
Fernand Labrie
, David Archer
, et al.
·
Menopause The Journal of The North American Menopause Society
·
190
Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause
2018
·
Fernand Labrie
, David F. Archer
, et al.
·
Menopause The Journal of The North American Menopause Society
·
120
Treatment of pain at sexual activity (dyspareunia) with intravaginal dehydroepiandrosterone (prasterone)
2015
·
David F. Archer
, Fernand Labrie
, et al.
·
Menopause The Journal of The North American Menopause Society
·
111
Serum steroid levels during 12-week intravaginal dehydroepiandrosterone administration
2009
·
Fernand Labrie
, David Archer
, et al.
·
Menopause The Journal of The North American Menopause Society
·
101
Effect of Intravaginal Prasterone on Sexual Dysfunction in Postmenopausal Women with Vulvovaginal Atrophy
2015
·
Fernand Labrie
, Leonard Derogatis
, et al.
·
The Journal of Sexual Medicine
·
94
Serum steroid concentrations remain within normal postmenopausal values in women receiving daily 6.5 mg intravaginal prasterone for 12 weeks
2016
·
Céline Martel
, Fernand Labrie
, et al.
·
The Journal of Steroid Biochemistry and Molecular Biology
·
73
Prasterone has parallel beneficial effects on the main symptoms of vulvovaginal atrophy: 52-week open-label study
2015
·
Fernand Labrie
, David F. Archer
, et al.
·
Maturitas
·
63
Effect of intravaginal dehydroepiandrosterone (DHEA) on the female sexual function in postmenopausal women: ERC-230 open-label study
2015
·
Céline Bouchard
, Fernand Labrie
, et al.
·
Hormone Molecular Biology and Clinical Investigation
·
55
Decreased efficacy of twice-weekly intravaginal dehydroepiandrosterone on vulvovaginal atrophy
2014
·
C. Bouchard
, F. Labrie
, et al.
·
Climacteric
·
45
High internal consistency and efficacy of intravaginal DHEA for vaginal atrophy
2010
·
Fernand Labrie
, David Archer
, et al.
·
Gynecological Endocrinology
·
40
Lack of Influence of Dyspareunia on the Beneficial Effect of Intravaginal Prasterone (Dehydroepiandrosterone, DHEA) on Sexual Dysfunction in Postmenopausal Women
2014
·
Fernand Labrie
, David Archer
, et al.
·
The Journal of Sexual Medicine
·
38
Serum steroids remain within the same normal postmenopausal values during 12-month intravaginal 0.50% DHEA
2015
·
Yuyong Ke
, Renaud Gonthier
, et al.
·
Hormone Molecular Biology and Clinical Investigation
·
31
Serum levels of sex steroids and metabolites following 12 weeks of intravaginal 0.50% DHEA administration
2015
·
Yuyong Ke
, Fernand Labrie
, et al.
·
The Journal of Steroid Biochemistry and Molecular Biology
·
30
Influence of treatment of vulvovaginal atrophy with intravaginal prasterone on the male partner
2015
·
F. Labrie
, M. Montesino
, et al.
·
Climacteric
·
16
Evaluation of the acceptability of intravaginal prasterone ovule administration using an applicator
2015
·
Marlene Montesino
, Fernand Labrie
, et al.
·
Gynecological Endocrinology
·
10
Effect of Intravaginal Prasterone (dhea) on Libido and Sexual Dysfunction in Postmenopausal Women
2009
·
C. Bouchard
, D. Archer
, et al.
·
Maturitas
·
5
Serum Steroid Levels During 12-week Intravaginal Dhea Administration
2009
·
F. Labrie
, D. Archer
, et al.
·
Maturitas
·
2
Intravaginal Prasterone (dhea), a Highly Efficient and the Only Physiological Treatment of Vaginal Atrophy
2009
·
F. Labrie
, D. Archer
, et al.
·
Maturitas
·
2
Influence of treatment of vulvovaginal atrophy with intravaginal prasterone on the male partner
2015
·
F. Labrie
, M. Montesino
, et al.
·
Figshare
Show more works
View as search
Works count:
22
Citation count:
1,468
H-index:
16
I10-index:
17
Year
Topic
Type
